The primary objective of this registry is to assess the safety and angiographic outcomes of endovascular treatment of intracranial aneurysms using the DeltaMaxx Microcoil System.
Study Type
OBSERVATIONAL
Primary Effectiveness Objective - Angiographic Outcomes
The Primary Effectiveness endpoint is the immediate post-procedure and 12-month angiographic occlusion rates assessed by the independent core lab using the modified Raymond-Roy Grading Scale (RRGS) scale
Time frame: 12 Months
Primary Safety Endpoint - Neurological Morbidity and Mortality
Neurological Morbidity and Mortality as determined by the NIH Stroke Scale and all-cause mortality, regardless of relationship to the treatment, will be captured over the course of the study
Time frame: 12 months
Packing Density
Packing density as measured by volumetric filling of the aneurysm post-procedure after the coils have been placed as indicated by angiographic films taken at the end of the coiling procedure
Time frame: 24 hours
Recurrence Rate
Time frame: 12 months
Re-treatment Rate
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.